Diagnosis, evolution and treatment of craneofaringiomas
Descripción del Articulo
Objective: To describe the clinical and metabolic characteristics of craniopharyngiomas. Material and methods: To descriptive, cross-sectional, retrospective study of 10 cases of sellar craniopharyngiomas of those who were attended in author´s private practice, collected from january 2 to march 31,...
Autor: | |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2025 |
Institución: | Fundación Instituto Hipólito Unanue |
Repositorio: | Diagnóstico |
Lenguaje: | español |
OAI Identifier: | oai:revistadiagnostico.fihu.org.pe:article/569 |
Enlace del recurso: | https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/569 |
Nivel de acceso: | acceso abierto |
Materia: | Hipotálamo hipófisis craneofaringiomas Hypothalamus. pituitary craniopharyngiomas |
id |
REVFIHU_3d1d8aaa22b3dcd0e97e00bab59139d6 |
---|---|
oai_identifier_str |
oai:revistadiagnostico.fihu.org.pe:article/569 |
network_acronym_str |
REVFIHU |
network_name_str |
Diagnóstico |
repository_id_str |
|
dc.title.none.fl_str_mv |
Diagnosis, evolution and treatment of craneofaringiomas Diagnóstico, evolución y tratamiento de los craneofaringiomas |
title |
Diagnosis, evolution and treatment of craneofaringiomas |
spellingShingle |
Diagnosis, evolution and treatment of craneofaringiomas Garmendia Lorena, Fausto Hipotálamo hipófisis craneofaringiomas Hypothalamus. pituitary craniopharyngiomas |
title_short |
Diagnosis, evolution and treatment of craneofaringiomas |
title_full |
Diagnosis, evolution and treatment of craneofaringiomas |
title_fullStr |
Diagnosis, evolution and treatment of craneofaringiomas |
title_full_unstemmed |
Diagnosis, evolution and treatment of craneofaringiomas |
title_sort |
Diagnosis, evolution and treatment of craneofaringiomas |
dc.creator.none.fl_str_mv |
Garmendia Lorena, Fausto |
author |
Garmendia Lorena, Fausto |
author_facet |
Garmendia Lorena, Fausto |
author_role |
author |
dc.subject.none.fl_str_mv |
Hipotálamo hipófisis craneofaringiomas Hypothalamus. pituitary craniopharyngiomas |
topic |
Hipotálamo hipófisis craneofaringiomas Hypothalamus. pituitary craniopharyngiomas |
description |
Objective: To describe the clinical and metabolic characteristics of craniopharyngiomas. Material and methods: To descriptive, cross-sectional, retrospective study of 10 cases of sellar craniopharyngiomas of those who were attended in author´s private practice, collected from january 2 to march 31, 2023. Information is given on age, weight, height, BMI, blood pressure,concentrations of prolactin (PRL), thyrotrophic hormone (TSH), luteotrophic hormone (LH), follicle-stimulating hormone (FSH), somatotropin (STH), thyroxine (T4), triiodo-thyronine (T3), cortisol (F), testosterone (T) in men, estradiol (E2) in women, glucose (G). Stimulatory tests with TRH, GnRH, insulin hypoglycemia, x-rays, ocular campimetry and treatment. Results: 30%women, 28.1±19,5 years old, weight 42.9±12,0 kg, height 1.35±0,12 m, BMI 23.3±3,91 BP 108.0/73.8 mmHg, PRL 26±3 ng/ml, STH 0.47±0.53 ng/ml ml, TSH 5.3±2.4mIU/L, LH 0.92±0.67IU/L, T4 4.8±3.7 ug/dl, T3 100±10 ng/dl, F 3.5 ±3 .78ug/dl, T1.76±1.26 ng/dL, E2 15.7±6.03 pg/ml G 79.3±6.15. TRH test: 7, 2.9, 4.2 mIU/L TSH. GnRH test: 1.09, 1.95, 3.03, 3.05, 1.17 IU/L LH. Insulin hypoglycemia: 0.43, 0.62, 0.47, 0.4, 0.43 ng/ml STH; 3.5, 4.17, 6.2, 6.43, 5.47 ug/dL cortisol. All showed an increasein the sella turcica, several with calcifications in the cystic images. The majority had vision impairment that led to blindness. They underwent transsphenoidal hypophysectomy. Two patients developed diabetes insipidus before the quirurgic treatment. Conclusions: Craniopharyngiomas had basal hormonal concentrations in the normal range and limited responses to stimulatory tests. |
publishDate |
2025 |
dc.date.none.fl_str_mv |
2025-05-18 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/569 10.33734/diagnostico.v64i1.569 |
url |
https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/569 |
identifier_str_mv |
10.33734/diagnostico.v64i1.569 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/569/542 |
dc.rights.none.fl_str_mv |
Derechos de autor 2025 Fausto Garmendia Lorena https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Derechos de autor 2025 Fausto Garmendia Lorena https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Fundación Instituto Hipólito Unanue |
publisher.none.fl_str_mv |
Fundación Instituto Hipólito Unanue |
dc.source.none.fl_str_mv |
Diagnóstico; Vol. 64 No. 1 (2025); e569 Diagnostico; Vol. 64 Núm. 1 (2025); e569 1018-2888 2709-7951 10.33734/diagnostico.v64i1 reponame:Diagnóstico instname:Fundación Instituto Hipólito Unanue instacron:FIHU |
instname_str |
Fundación Instituto Hipólito Unanue |
instacron_str |
FIHU |
institution |
FIHU |
reponame_str |
Diagnóstico |
collection |
Diagnóstico |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1845890288890937344 |
spelling |
Diagnosis, evolution and treatment of craneofaringiomasDiagnóstico, evolución y tratamiento de los craneofaringiomasGarmendia Lorena, FaustoHipotálamohipófisiscraneofaringiomasHypothalamus. pituitarycraniopharyngiomasObjective: To describe the clinical and metabolic characteristics of craniopharyngiomas. Material and methods: To descriptive, cross-sectional, retrospective study of 10 cases of sellar craniopharyngiomas of those who were attended in author´s private practice, collected from january 2 to march 31, 2023. Information is given on age, weight, height, BMI, blood pressure,concentrations of prolactin (PRL), thyrotrophic hormone (TSH), luteotrophic hormone (LH), follicle-stimulating hormone (FSH), somatotropin (STH), thyroxine (T4), triiodo-thyronine (T3), cortisol (F), testosterone (T) in men, estradiol (E2) in women, glucose (G). Stimulatory tests with TRH, GnRH, insulin hypoglycemia, x-rays, ocular campimetry and treatment. Results: 30%women, 28.1±19,5 years old, weight 42.9±12,0 kg, height 1.35±0,12 m, BMI 23.3±3,91 BP 108.0/73.8 mmHg, PRL 26±3 ng/ml, STH 0.47±0.53 ng/ml ml, TSH 5.3±2.4mIU/L, LH 0.92±0.67IU/L, T4 4.8±3.7 ug/dl, T3 100±10 ng/dl, F 3.5 ±3 .78ug/dl, T1.76±1.26 ng/dL, E2 15.7±6.03 pg/ml G 79.3±6.15. TRH test: 7, 2.9, 4.2 mIU/L TSH. GnRH test: 1.09, 1.95, 3.03, 3.05, 1.17 IU/L LH. Insulin hypoglycemia: 0.43, 0.62, 0.47, 0.4, 0.43 ng/ml STH; 3.5, 4.17, 6.2, 6.43, 5.47 ug/dL cortisol. All showed an increasein the sella turcica, several with calcifications in the cystic images. The majority had vision impairment that led to blindness. They underwent transsphenoidal hypophysectomy. Two patients developed diabetes insipidus before the quirurgic treatment. Conclusions: Craniopharyngiomas had basal hormonal concentrations in the normal range and limited responses to stimulatory tests.Objetivo: Describir las características clínicas y metabólicas de los craneofaringiomas, tumores congénitos, restos de la bolsa de Rathke, que suelen aparecer encima de la glándula pituitaria. Material y métodos: Estudio descriptivo, transversal, retrospectivo de 10 historias clínicas de craneofaringiomas sellares, de pacientes que asistieron a la práctica privada del autor. Se informa sobre la edad, peso, talla, IMC, presión arterial, concentraciones de prolactina (PRL), hormona tirotrófica (TSH), luteotrófica (LH), folículo-estimulante (FSH), somatotropina (STH), tiroxina (T4), triiodo-tironina (T3), cortisol (F), testosterona (T) en varones, estradiol (E2) en mujeres, glucosa (G). Pruebas estimulatorias con TRH, GnRH, hipoglicemia insulínica, radiografías, campimetrías oculares y tratamiento. Resultados: 30% mujeres, 28,1±19,5 años, peso 42,9±12,0 kg, talla 1.35±0,12 m, IMC 23,3±3,91 PA 108,0/73,8 mmHg, PRL 26±3 ng/ml, STH 0,47±0,53 ng/ml, TSH 5,3±2,4 mUI/L, LH 0,92±0,67UI/L, T4 4,8±3,7 ug/dl, T3 100±10 ng/dl , F 3,5 ±3,78ug/dl, T 1,76±1,26 ng/dL, E2 15,7±6,03 pg/ml G 79,3±6,15. Prueba TRH: 7, 2,9, 4,2 mUI/L de TSH. Prueba GnRH: 1,09, 1,95, 3,03, 3,05, 1,17 UI/L de LH. Hipoglicemia insulínica: 0,43, 0,62, 0,47, 0,4, 0,43 ng/ml de STH; 3,5, 4,17, 6,2, 6,43, 5,47 ug/dL de cortisol. Todos mostraron incremento de la silla turca, varios con calcificaciones en lasimágenes quísticas. La mayoría tuvo compromiso de la visión que llegó hasta la ceguera. Fueron sometidos a hipofisectomía transesfenoidal. Dos pacientes desarrollaron diabetes insípida antes del tratamiento quirúrgico. Conclusiones: Los craneofaringiomas tuvieron concentraciones hormonales basales dentro del rango normal y respuestas limitadas a las pruebas estimulatorias.Fundación Instituto Hipólito Unanue2025-05-18info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/56910.33734/diagnostico.v64i1.569Diagnóstico; Vol. 64 No. 1 (2025); e569Diagnostico; Vol. 64 Núm. 1 (2025); e5691018-28882709-795110.33734/diagnostico.v64i1reponame:Diagnósticoinstname:Fundación Instituto Hipólito Unanueinstacron:FIHUspahttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/569/542Derechos de autor 2025 Fausto Garmendia Lorenahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:revistadiagnostico.fihu.org.pe:article/5692025-08-24T00:19:54Z |
score |
13.325744 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).